Finance

Beta
Lists
REPCF:OTCMKTS
RepliCel Life Sciences Inc
0,00010 $
0,00%
(0,00) 1D
6 ապր, 12:04:36 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REPCF...
Mkt. cap
7,36 հզր
Volume
0,00
52-wk high
0,00 $
52-wk low
0,00 $
EPS
-0,00 $
Shares outstanding
70,01 մլն
No. of employees
1
Mkt. cap
7,36 հզր
Volume
0,00
52-wk high
0,00 $
52-wk low
0,00 $
EPS
-0,00 $
Shares outstanding
70,01 մլն
No. of employees
1
News stories
From sources across the web
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle. The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
About RepliCel Life Sciences Inc
CEO-
Employees1
Founded1967
HeadquartersՎանքուվեր, Բրիտանական Կոլումբիա, Կանադա
Sector-
Websitereplicel.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
-
-
-
88,43 հզր
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
2,31 հզր
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,72 հզր
5,25 հզր
-
10,25 հզր
Operating expense
21,72 հզր
7,56 հզր
-
10,25 հզր
Total operating expenses
21,72 հզր
7,56 հզր
-
10,25 հզր
Operating income
-21,72 հզր
-7,56 հզր
-
78,18 հզր
Other non operating income
-
-
-
-114,63 հզր
EBT including unusual items
-28,65 հզր
-25,10 հզր
-
-47,46 հզր
EBT excluding unusual items
-28,65 հզր
-25,10 հզր
-
-47,46 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28,65 հզր
-25,10 հզր
-
-47,46 հզր
Net profit margin
-
-
-
-53,67%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6,93 հզր
-17,54 հզր
-
-11,48 հզր
Net interest expenses
-6,93 հզր
-17,54 հզր
-
-11,48 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,58 հզր
-7,42 հզր
-
-
Gain or loss from assets sale
1,65 հզր
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer